Partners Capital Investment Group, LLP Kronos Bio, Inc. Transaction History
Partners Capital Investment Group, LLP
- $5.87 Billion
- Q3 2024
A detailed history of Partners Capital Investment Group, LLP transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 1,611,512 shares of KRON stock, worth $1.51 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,611,512
Previous 1,665,797
3.26%
Holding current value
$1.51 Million
Previous $2.07 Million
21.99%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding KRON
# of Institutions
56Shares Held
19.8MCall Options Held
9.3KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.6 Million3.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.92 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.81 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.35 Million0.1% of portfolio
-
Acadian Asset Management LLC Boston, MA1.3MShares$1.23 Million0.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $53.4M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...